Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Naz Rahman is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
06/26/2024 | PRFX | Buy Now | PainReform | $0.51 | 292.62% | $2 → $2 | Reiterates | Buy → Buy | Get Alert |
06/25/2024 | ALIM | Buy Now | Alimera Sciences | $5.55 | — | — | Downgrade | Buy → Hold | Get Alert |
06/04/2024 | VKTX | Buy Now | Viking Therapeutics | $53.10 | 125.99% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
05/22/2024 | VRPX | Buy Now | Virpax Pharmaceuticals | $0.52 | — | — | Downgrade | Buy → Hold | Get Alert |
05/01/2024 | PALI | Buy Now | Palisade Bio | $4.50 | 400% | → $22.5 | Reiterates | Buy → Buy | Get Alert |
04/16/2024 | PALI | Buy Now | Palisade Bio | $4.50 | 400% | $22.5 → $22.5 | Maintains | Buy | Get Alert |
03/25/2024 | ALIM | Buy Now | Alimera Sciences | $5.55 | 80.2% | → $10 | Initiates | → Buy | Get Alert |
03/18/2024 | AGRX | Buy Now | Agile Therapeutics | $1.41 | — | — | Downgrade | Buy → Hold | Get Alert |
03/15/2024 | VKTX | Buy Now | Viking Therapeutics | $53.10 | 125.99% | → $120 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | QNRX | Buy Now | Quoin Pharmaceuticals | $0.58 | 583.76% | $15 → $4 | Maintains | Buy | Get Alert |
02/08/2024 | VKTX | Buy Now | Viking Therapeutics | $53.10 | -5.84% | $35 → $50 | Maintains | Buy | Get Alert |
01/31/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | — | — | Downgrade | Buy → Hold | Get Alert |
12/19/2023 | CING | Buy Now | Cingulate | $0.35 | — | — | Downgrade | Buy → Hold | Get Alert |
12/18/2023 | CING | Buy Now | Cingulate | $0.35 | — | — | Downgrade | Buy → Hold | Get Alert |
12/08/2023 | PTPI | Buy Now | Petros Pharma | $0.46 | 773.36% | → $4 | Initiates | → Buy | Get Alert |
11/17/2023 | PCSA | Buy Now | Processa Pharma | $2.00 | — | — | Downgrade | Buy → Hold | Get Alert |
11/17/2023 | PALI | Buy Now | Palisade Bio | $4.50 | -66.67% | → $22.5 | Upgrade | Hold → Buy | Get Alert |
09/22/2023 | AGRX | Buy Now | Agile Therapeutics | $1.41 | 253.61% | → $5 | Upgrade | Hold → Buy | Get Alert |
08/09/2023 | AYTU | Buy Now | Aytu BioPharma | $2.91 | 71.92% | → $5 | Initiates | → Buy | Get Alert |
05/11/2023 | SCPH | Buy Now | scPharmaceuticals | $4.35 | 359.77% | $13 → $20 | Maintains | Buy | Get Alert |
03/30/2023 | PALI | Buy Now | Palisade Bio | $4.50 | 1011.11% | → $750 | Upgrade | Hold → Buy | Get Alert |
01/12/2023 | PCSA | Buy Now | Processa Pharma | $2.00 | 150% | $180 → $100 | Maintains | Buy | Get Alert |
12/20/2022 | VKTX | Buy Now | Viking Therapeutics | $53.10 | -71.75% | $10 → $15 | Maintains | Buy | Get Alert |
11/22/2022 | CING | Buy Now | Cingulate | $0.35 | 758.86% | → $60 | Initiates | → Buy | Get Alert |
08/22/2022 | CRXT | Buy Now | Clarus Therapeutics Hldgs | — | — | — | Downgrade | Buy → Hold | Get Alert |
08/19/2022 | PALI | Buy Now | Palisade Bio | $4.50 | — | — | Downgrade | Buy → Hold | Get Alert |
08/02/2022 | SCPH | Buy Now | scPharmaceuticals | $4.35 | — | — | Initiates | → Buy | Get Alert |
07/26/2022 | AGRX | Buy Now | Agile Therapeutics | $1.41 | -29.28% | → $50 | Upgrade | Hold → Buy | Get Alert |
06/09/2022 | VRPX | Buy Now | Virpax Pharmaceuticals | $0.52 | 673.25% | → $40 | Initiates | → Buy | Get Alert |
05/09/2022 | ATNF | Buy Now | 180 Life Sciences | $1.55 | — | — | Downgrade | Buy → Hold | Get Alert |
04/19/2022 | PCSA | Buy Now | Processa Pharma | $2.00 | 350% | → $180 | Initiates | → Buy | Get Alert |
02/25/2022 | NXGL | Buy Now | NexGel | $2.29 | 162.01% | → $6 | Initiates | → Buy | Get Alert |
01/07/2022 | QNRX | Buy Now | Quoin Pharmaceuticals | $0.58 | 754.7% | → $750 | Initiates | → Buy | Get Alert |
01/07/2022 | NRSN | Buy Now | NeuroSense Therapeutics | $1.11 | 530.63% | → $7 | Initiates | → Buy | Get Alert |
12/07/2021 | FWBI | Buy Now | First Wave BioPharma | — | — | — | Downgrade | Buy → Hold | Get Alert |
08/31/2021 | PALI | Buy Now | Palisade Bio | $4.50 | 55.56% | → $5250 | Initiates | → Buy | Get Alert |